Using synthetic biology and AI to address global antimicrobial resistance threat
Driven by overuse and misuse of antibiotics, drug-resistant infections are on the rise, while development of new antibacterial tools has slowed.
Driven by overuse and misuse of antibiotics, drug-resistant infections are on the rise, while development of new antibacterial tools has slowed.
Opening a new window on the brainstem, a new tool reliably and finely resolves distinct nerve bundles in live diffusion MRI scans, revealing signs of injury or disease.
Professor James Collins discusses how collaboration has been central to his research into combining computational predictions with new experimental platforms.
New research detects hidden evidence of mistaken correlations — and provides a method to improve accuracy.
Nanoparticles coated with molecular sensors could be used to develop at-home tests for many types of cancer.
New research demonstrates how AI models can be tested to ensure they don’t cause harm by revealing anonymized patient health data.
New research suggests liver cells exposed to too much fat revert to an immature state that is more susceptible to cancer-causing mutations.
The Hood Pediatric Innovation Hub brings together clinicians, researchers, and industry to bridge the gap between discovery and care.
Angela Koehler, Iain Cheeseman, and Katharina Ribbeck are shaping the collaborative as a platform for transformative research, translation, and talent development across MIT.
Faculty members and researchers were honored in recognition of their scholarship, service, and overall excellence.
Large language models can learn to mistakenly link certain sentence patterns with specific topics — and may then repeat these patterns instead of reasoning.
Using these nanoparticles to deliver a flu vaccine, researchers observed an effective immune response at a much lower dose.
MIT PhD students who interned with the MIT-IBM Watson AI Lab Summer Program are pushing AI tools to be more flexible, efficient, and grounded in truth.
MIT researchers show they can use messenger RNA to activate the pathway and trigger the immune system to attack tumors.
A presidential initiative, the MIT Human Insight Collaborative is supporting new interdisciplinary initiatives and projects across the Institute.